Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both.

Area of Science:

• Cardiovascular Research
• Mitochondrial Biology
• Pulmonary Medicine

Background:

• Pulmonary hypertension (PH) is a progressive disease characterized by increased pulmonary artery pressure and vascular remodeling.
• Clinical manifestations include dyspnea, right ventricular dysfunction, and heart failure, with poor survival rates in advanced stages.
• Metabolic theories suggest mitochondrial dysfunction plays a key role in PH pathogenesis.

Purpose of the Study:

• To review the current understanding of mitochondrial dysfunction in pulmonary hypertension pathobiology.
• To explore potential therapeutic targets within pulmonary vascular processes related to mitochondria.
• To highlight the similarities between cancer pathobiology and PH, particularly regarding unregulated proliferation and angiogenesis.

Main Methods:

• This is a review article, synthesizing existing research on pulmonary hypertension and mitochondrial function.
• It examines the role of mitochondrial components like the electron transport chain, redox enzymes, and mitophagy.
• The review also considers the implications of mitochondrial dysfunction on endothelial cells and angiogenesis.

Main Results:

• Mitochondrial dysfunction contributes to impaired vascular relaxation, increased cell proliferation, and regulatory failure in pulmonary hypertension.
• Evidence suggests a link between mitochondria, angiogenesis, and the "plexiform lesions" characteristic of advanced PH.
• Mitochondria-targeting strategies are emerging as feasible therapeutic avenues.

Conclusions:

• Mitochondrial dysfunction is a critical factor in the pathobiology of pulmonary hypertension.
• Understanding these mechanisms opens doors for novel therapeutic strategies targeting mitochondria.
• Further research is needed to fully elucidate the role of endothelial cell-specific mitochondrial dysfunction and its microenvironment interactions.